SEC Form 4 · accession 0001628280-19-002854
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Tobin
Director
Period of report
Mar 12, 2019
Accepted (ET)
Mar 13, 2019 · 2:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 12, 2019 | M | 5,000 | $6.66 | A | 56,568 | D | |
| Common Stock | Mar 12, 2019 | F | 2,691 | $6.66 | D | 53,877 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nonstatutory Stock Option (Right to Buy) | $6.66 | Mar 12, 2019 | M | 5,000 | D | May 16, 2012 | May 16, 2019 | Common Stock | 5,000 | 0 | D |